ISG15 and ISGylation in Human Diseases is a research paper published in Cells (2022). On theSindex it has a DataRank of 0. It has been cited 116 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
The A-T Children’s Project Foundation
Grant: NA
NIH/NINDS
Grant: R21NS060960
National Institutes of Health
Grant: 1R21NS060960-01A2
Deregulation of the Ubiquitin/26S Proteasome Pathway in AT cells: Role of ISG15
NIAAA NIH HHS
Grant: P60 AA009803
NIAAA NIH HHS
Grant: T32 AA007577
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of ISGylation is induced in neurons by demyelination driving ISG15-dependent microglial activation
Additional file 1 of ISGylation is induced in neurons by demyelination driving ISG15-dependent microglial activation
Additional file 1 of HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis
Additional file 1 of HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis
Additional file 4 of HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis
Additional file 3 of HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis
Additional file 2 of HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis
Additional file 2 of HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis
Additional file 3 of HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis
Additional file 4 of HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis